Multiplexed enzymatic assays

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S968000, C435S015000, C435S966000, C435S975000, C435S007100

Reexamination Certificate

active

06630296

ABSTRACT:

TECHNICAL FIELD
The field of this invention is enzyme assays, and in particular, assays involving multiplexed substrates and, optionally multiplexed enzymes.
REFERENCES
Blakesley V. A., Scrimgeour A., Esposito D., Roith D. L., Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling?, Cytokine & Growth factor reviews (1996), Vol. 1, 2, pp. 153-159.
Bunemann M., Hosey M. M., G-protein coupled receptor kinases as modulators of G-protein signaling, J. of Physiology (1999), 517, 1, pp.5-23.
Cantley, L. C. et al Signal Transduction in Health and Disease, Advances in Second Messenger and Phosphoprotein Research, Vol. 31, 41-48, 1997.
Cohen, C. B. et al Anal. Biochem. Vol 273, 89-97, 1999. Pike L. J., Gallis B., Casnellie J. E., Bornstein P., Krebs E. G., Epidermal growth factor stimulates the phosphorylation of synthetic tyrosine-containing peptides by A431 cell membranes,PNAS, USA 79 (1982), pp.1443-1447.
Nanjee, M. N. Clinical Chemistry, Vol. 42(6), 915-926, 1996.
Osorio C. R. et al Dis. Aquat. Organ. Vol. 40(3), 177-183, 2000.
Pike L. J., Kuenzel E. A., Casnellie J. E., Krebs E. G., A comparison of insulin- and epidermal growth factor-stimulated protein kinases from human placenta, J. of Biol. Chem. (1984), 259, 15, pp.9913-9921.
Sasaki N., Rees-Jones R. W., Zick Y., Nissley S. P., Rechler M. M., Characterization of insulin-like growth factor I-stimulated tyrosine kinase activity associated with the &bgr;-subunit of type I insulin-like growth factor receptor of rat liver cells, J. of Biol. Chem. (1985), Vol. 260, 17, pp.9793-9804.
White M. F., Kahn C. R., The Insulin Receptor and Tyrosine Phosphorylation, The Enzymes, Vol. XVII, pp.248-310, 1986.
White, M. F. et al The Enzymes Vol. XVII, 247-311, 1986.
Zhou M., Felder S., Rubinstein M., Hurwitz D. R., Ullrich A., Lax I., Schlessinger J., Real time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimmers support the dimerization model for receptor activation, Biochemistry (1993), 32, 8193-8198.
BACKGROUND OF THE INVENTION
There are numerous situations where one is interested in performing a multiplicity of determinations in a single vessel and being able to individually determine the result of each determination. In order to be able to achieve the individual results, it is necessary that each determination be independent of the other determinations, and that each determination provide a product that can be measured and distinguished from the products of the other determinations.
One of the areas of interest is the effect of a change in environment on a plurality of enzymes. In screening compounds for biological activity, one is interested in the effect of the compound on one or more targets, as well as the effect of the compound on enzymes that are not targets. Therefore, if one can perform a single determination under the same conditions, so as to determine the effect of the compound on a plurality of enzymes, one can not only determine the biological activity of the compound as to targets of interest, but also the specificity of the compound in relation to side effects.
Besides screening compounds for biological activity, there is also an interest in determining the effect of a change in environment on cellular activity, as to specific enzymes. For cancer cells, one would be interested in determining changes in the cellular expression of proteins, the activity of individual enzymes, or an enzyme profile in relation to a compound or course of treatment.
One special class of enzymes for which enzyme multiplexing would be advantageous is cell-surface or intracellular receptors, which represent a significant class of targets for drug screening because the receptors are involved in cell growth and metabolism. Many receptors have enzyme domains, such as the insulin receptor, insulin-like growth factor receptor, epidermal growth factor, and platelet-derived growth factor (White). Some receptors can be coupled to enzyme for assaying the receptors (Bunemann). When a ligand binds to the specific site of a receptor, it typically activates the receptor's enzyme domain. In many cases, the enzyme is protein kinase that can be measured by determination of the rate of phosphorylation of a synthetic peptide. Since many receptors have high affinity to their specific ligands (Pike, 1984, Blakesley, Sasaki), it is possible to develop a method to perform the receptor assay by monitoring their enzyme (kinase) activity. Since only the specifically bound, natural ligand has the potential to activate the enzyme domain, the receptor assay by monitoring its enzyme activity may avoid the non-specific binding issue. This approach can be used for both ligand binding assay and enzyme assay for many receptors, especially for hormones and growth factor receptors.
In screening for compounds that are capable of inhibiting ligand/receptor binding, there are two, and sometimes three, variables that must be screened. The first variable is the test compound itself, e.g., a large number of test compounds derived from a library of potential inhibitors of ligand/receptor interaction. The second variable is test-compound concentration, relative to the concentration of receptor ligand. The third variable is the effect of the test compound on other enzymes, e.g., other receptor kinases on or in the target cell. Testing for and optimizing the concentration of test compounds, and assaying their effect on other cellular enzymes ultimately requires a large number of assay samples. By combining one or more of the test variables in a multiplexed assay, one could substantially reduce the number of assay that needed to be performed and/or provide an internal control for multiple assays.
SUMMARY OF THE INVENTION
In one aspect, the invention includes a multiplexed enzyme assay method. The method includes performing a plurality of enzyme reactions in the presence of plurality of enzymes substrates in a set of substrates, under conditions effective to convert an enzyme substrate to a corresponding product, where the product of each substrate and the substrate have different separation characteristics from each other and from the other substrates in the set and their corresponding products. After performing the reactions, the products, and preferably also the substrates in the reactions are separated in a single separation medium. For each separated product and substrate, a separation characteristic effective to identify that product and substrate and a signal related to the amount of the product and substrate is detected. From this, the amount of substrate converted to the corresponding product in each of the reactions can be determined.
The separation characteristic of the substrates and products is preferably electrophoretic mobility in an electrophoretic medium under the influence of an electric field, although other separation characteristics, such as behavior when separated by exclusion or ion-exchange chromatography, isoelectric focusing or mass spectroscopy are also contemplated. The substrates and corresponding products may be fluorescent-labeled, where the detecting includes detecting the fluorescent signal from each product when irradiated with a fluorescence-excitation wavelength.
In one general embodiment, the plurality of enzyme reactions are carried out in a single reaction mixture containing a plurality of different enzymes, where each of the enzymes being assayed is effective to convert one of the substrates in the reaction mixture to the corresponding product. The embodiment may be used, for example, to determine the levels of activity of each of a plurality of different enzymes in a cell, under selected cell conditions, where the different enzymes in the reaction mixture are obtained from the cell under such selected cell conditions.
For use in determining changes in the levels of activity of each of a group of enzymes in a cell, in both control and test cell conditions, the performing, separating, detecting, and determining steps are carried out for enzymes obtained from the cells

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Multiplexed enzymatic assays does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multiplexed enzymatic assays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multiplexed enzymatic assays will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3138562

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.